Cashu
Corbus Pharmaceuticals Holdings: Key Developments and Future Prospects.
2 minutes ago
Stocks
Health Care
crbp
Corbus Pharmaceuticals Holdings
CRBP
+0.43 (+5.86%)
7.77
USD
At close at May 19, 20:39 UTC
Overview
Key Stats
Market Cap
89.78M
Dividend Yield
0.00%
P/E Ratio
-1.79
EPS
-3.64
Revenue
-
Avg. Volume
128.27K
About
What does CRBP do?
Corbus Pharmaceuticals, based in Norwood, Massachusetts, focuses on developing therapies for rare inflammatory diseases and cancer, with a pipeline including CRB-701 and CRB-601. The company went public on October 24, 2014, and employs 19 staff.
Join our newsletter to keep up to date with us!
